Rush University Cancer Center, Chicago Blood Cancer Foundation and Hope for Lymphoma wish to thank TEVA Oncology, a division of Teva Pharmaceuticals, for its generous funding as the Presenting Supporter of this program.
Rush University Cancer Center, Chicago Blood Cancer Foundation and Hope for Lymphoma wish to thank the Celgene Corporation for its generous funding and support of this program.
Rush is a not-for-profit health care, education and research enterprise comprising Rush University Medical Center, Rush University, Rush Oak Park Hospital and Rush Health.
The Rush University Cancer Center comprises all of the cancer-related clinical, research and educational efforts at Rush, crossing 20 departments, divisions and sections; inpatient and outpatient areas; professional clinical activities; and the colleges of Rush University.
site design: tankhousepictures.com
